
Debra Richardson, M.D.
@debbieric23
Professor, Gyn Oncologist, dog and cat mom. Opinions are my own.
ID: 1504984846656937985
19-03-2022 00:55:51
120 Tweet
286 Followers
197 Following

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT552… pubmed.ncbi.nlm.nih.gov/39231383/ Proud of our OU Health Stephenson Cancer Center phase 1 team, Debra Richardson, M.D. , Vivek Subbiah, MD , Meredith McKean MD, MPH and the Sarah Cannon Docs team. Innovation in

New #JITC article: First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer bit.ly/42dhXSC Debra Richardson, M.D. Erika Hamilton, MD


The SGO Winter Meeting is the premier oncology winter/ski conference, & in the gorgeous backdrop of Whistler Blackcomb! ⛷️🏔️🌲 Can't wait for this fabulous mtg--great education, networking sessions, & fun led by Ritu Salani, Wendel Naumann, tom krivak, & Marilyn Huang !




Congratulations to my partner DrKatyMoore- one of the top cited researchers in the world! She’s amazing.




Registration & Housing for the WAGO 2025 Annual Meeting is Now Open! To register, click link in bio or go to ow.ly/p5ho50VlSQz. To book hotel reservations, click link in bio or go to ow.ly/loV650VlSQB. #WAGO2025 #WAGO Joshua Garrett Cohen DrDanaChase

New #JITC article: Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer bit.ly/3FvyBUf Debra Richardson, M.D. Rafeh Naqash, MD OU Health Stephenson Cancer Center



Another scientific advancement for our pts w/ LGSOC- a real boon for pts where more effective to options are needed SGO @GOGF IGCS ASCO ESMO - Eur. Oncology GYN Cancer | #GYNCSM

#ASCO25 OU Health Stephenson Cancer Center Debra Richardson, M.D. Emi-Le(B7H4 ADC) Proud to have this open and available to our patients in OKC
